IL315046A - Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin - Google Patents

Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin

Info

Publication number
IL315046A
IL315046A IL315046A IL31504624A IL315046A IL 315046 A IL315046 A IL 315046A IL 315046 A IL315046 A IL 315046A IL 31504624 A IL31504624 A IL 31504624A IL 315046 A IL315046 A IL 315046A
Authority
IL
Israel
Prior art keywords
hypertriglyceridemia
cyclodextrin
hydroxypropyl
beta
treatment
Prior art date
Application number
IL315046A
Other languages
English (en)
Hebrew (he)
Inventor
Jason Camm
Original Assignee
Beren Therapeutics P B C
Jason Camm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beren Therapeutics P B C, Jason Camm filed Critical Beren Therapeutics P B C
Publication of IL315046A publication Critical patent/IL315046A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL315046A 2022-02-18 2023-02-17 Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin IL315046A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263311536P 2022-02-18 2022-02-18
PCT/IB2023/051467 WO2023156970A1 (en) 2022-02-18 2023-02-17 Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin

Publications (1)

Publication Number Publication Date
IL315046A true IL315046A (en) 2024-10-01

Family

ID=85476260

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315046A IL315046A (en) 2022-02-18 2023-02-17 Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin

Country Status (11)

Country Link
US (1) US20240398849A1 (https=)
EP (1) EP4479064A1 (https=)
JP (1) JP2025508660A (https=)
KR (1) KR20240148426A (https=)
CN (1) CN118715017A (https=)
AU (1) AU2023222567A1 (https=)
CA (1) CA3244447A1 (https=)
IL (1) IL315046A (https=)
MX (1) MX2024010110A (https=)
TW (1) TW202342072A (https=)
WO (1) WO2023156970A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0307518A (pt) * 2002-02-01 2004-12-28 Shimoda Biotech Pty Ltd Composição farmacêutica
CN1745746A (zh) * 2004-09-09 2006-03-15 天津药物研究院 冰片的羟丙基-β-环糊精包合物及其制剂和制备方法
CN1961892A (zh) * 2005-11-08 2007-05-16 天津药物研究院 降香羟丙基-β-环糊精包合物及其制剂和制备方法
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
JP5847721B2 (ja) * 2009-10-08 2016-01-27 ソン、ホ、バイオメッド、カンパニー、リミテッドSong Ho Biomed Co., Ltd 高水溶性2−ヒドロキシプロピル−ベータシクロデキストリンを有効成分として含有する、肥満疾患の予防および治療用組成物
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl

Also Published As

Publication number Publication date
WO2023156970A1 (en) 2023-08-24
JP2025508660A (ja) 2025-04-10
AU2023222567A1 (en) 2024-09-19
US20240398849A1 (en) 2024-12-05
KR20240148426A (ko) 2024-10-11
CA3244447A1 (en) 2023-08-24
MX2024010110A (es) 2024-08-30
EP4479064A1 (en) 2024-12-25
TW202342072A (zh) 2023-11-01
CN118715017A (zh) 2024-09-27

Similar Documents

Publication Publication Date Title
GB202103774D0 (en) Detectiion of Ransomware
KR102423280B9 (ko) Sot-mram 면적 최적화 기법
GB202411655D0 (en) Application of circHIF1a
GB202008127D0 (en) Sterlisation of endoscopes
IL315046A (en) Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin
GB202107994D0 (en) Treatment of cancer
CA206768S (en) Part of syringe
CA203409S (en) Part of syringe
HUE066653T2 (hu) Cholangiopathiák kezelése seladelparral
GB202001353D0 (en) Treatment of skin conditions
GB202101251D0 (en) Treatment of conditions
GB202315695D0 (en) TReatment of cariomyopathy
GB202212506D0 (en) Treatment of covid-19
PL4274930T3 (pl) Obróbka tlenem włókien o wysokiej liczbie kappa
GB202209105D0 (en) Use of conjugates
GB202307686D0 (en) Treatment of conditions
GB202010319D0 (en) Treatment of biofilms
GB2607963B (en) Manufacture of pipelines
GB202306126D0 (en) Treatment of rapamycin-sensitive conditions
GB202109108D0 (en) Use of conjugates
GB202100761D0 (en) Treatment of osteoarthritic pain
GB202215264D0 (en) Use of urolithins
GB202118006D0 (en) Methods of treatment
GB202118007D0 (en) Methods of treatment
GB202118011D0 (en) Methods of treatment